TICKERNERD
Menu
PACSPACSHealthcare · Medical Care Facilities

PACS Stock Forecast: PACS Group, Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026
$42
+0.14% on the day

The 6 Wall Street analysts covering PACS Group, Inc. hold a median 12-month price target of $59 — +40.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 93 of 100 as at 19 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$6.7B
Ticker Nerd rank
93 / 100
Median analyst target
$59
Analysts covering
6
Revenue$1.4B+9.1% y/y
Operating income$109.3M
Net income$76.3M
Free cash flow$4.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.9%
1M
−3.8%
YTD
+9.7%
1Y
+251.0%
From 52W high
−13.1%
From 52W low
+298.1%
$11
$48
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PACS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores PACS Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026
93 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
97
Revisions
89
Growth
86
Issuance
83
Value
66
Accruals
64
Volatility
61
Quality
43
Size
19

Momentum (97): The shares have been drifting up relative to others.

Quality (43): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (19): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PACS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PACS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40$50$60$70Oct 25Jan 26Apr 26Jul 26PACSHigh $62Median $59Low $57

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says6 analysts
6 Buy0 Hold0 Sell
Low $57Median $59High $62

The green dot is the last close — the median target sits +40.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
4 Sept 2026JP MorganMaintainsOverweight$47 → $58
4 Sept 2026JP MorganMaintainsOverweight—
10 Aug 2026OppenheimerMaintainsOutperform$48 → $57
10 Aug 2026OppenheimerMaintainsOutperform—
6 Aug 2026RBC CapitalMaintainsOutperform$52 → $57
6 Aug 2026RBC CapitalMaintainsOutperform—
6 Aug 2026Truist SecuritiesMaintainsBuy$52 → $62
6 Aug 2026Truist SecuritiesMaintainsBuy—
6 Aug 2026UBSMaintainsBuy—
6 Aug 2026UBSMaintainsBuy$57 → $60
8 July 2026UBSMaintainsBuy—
8 July 2026UBSMaintainsBuy$50 → $57
18 May 2026Truist SecuritiesMaintainsBuy—
13 May 2026OppenheimerMaintainsOutperform—
4 Mar 2026OppenheimerMaintainsOutperform—
4 Mar 2026UBSMaintainsBuy—
27 Feb 2026RBC CapitalMaintainsOutperform—
18 Dec 2025UBSReinstatesBuy$50 → $42
17 Dec 2025JP MorganReinstatesOverweight$44
20 Nov 2025RBC CapitalMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PACS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

PACS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, PACS Group, Inc. returned +251.0% against +16.3% for the S&P 500, dividends included.

PACS vs S&P 500, last 12 monthsTotal return, rebased to 100
100200300400Oct 25Jan 26Apr 26Jul 26PACSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PACS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+19.8%
Analysts raising
4
Analysts cutting
0
Fundamentals

PACS Group, Inc. (PACS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
24.6×

Cheaper than 30% of US stocks

Price / sales
1.2×

Cheaper than 65% of US stocks

Price / book
6.0×

Cheaper than 17% of US stocks

EV / EBITDA
20.7×

Cheaper than 14% of US stocks

Growth & margins
Revenue growth (YoY)
9.1%

Higher than 49% of US stocks

Earnings growth (YoY)
49.9%

Higher than 74% of US stocks

Gross margin
17.1%

Higher than 17% of US stocks

Operating margin
7.7%

Higher than 60% of US stocks

Net margin
4.8%

Higher than 59% of US stocks

Returns & dividend
Return on equity
27.9%

Higher than 87% of US stocks

Return on assets
4.6%

Higher than 74% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

PACS Group, Inc. (PACS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • PACS Group, Inc. has a market value of $6.7B and an enterprise value of $9.9B.

  • Revenue in the twelve months to 30 June 2026: $5.6B. The latest quarter grew 9.1% year on year.

  • Net income over the same four quarters: $269.1M, a 4.8% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $121.5M.

  • Shares outstanding: 158.3M.

  • Trailing P/E: 24.6×; forward P/E: 15.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • PACS Group, Inc. employs 47,455 people — $117K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 19 Sept 2026

Data provided by Twelve Data

Peers

PACS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
PACSPACS Group, Inc.$6.7B
93
CHEChemed Corp.$6.8B
88
LFSTLifestance Health Group, Inc.$4.9B
95
CONConcentra Group Holdings Parent, Inc.$4.5B
95
ENSGThe Ensign Group, Inc.$10.1B
65
UHSUniversal Health Services, Inc.$10.4B
68
OPCHOption Care Health, Inc.$3.8B
82

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own PACS Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PACS news & analysis

PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026

Business Wire · 14 Sept 2026neutral

PACS Group, Inc. announced that it will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026, in Nashville, TN. CEO and Chairman Jason Murray, CFO Carey Hendrickson, and COO Josh Jergensen will present on the Company's operations, growth strategy, and related information.

Why it matters — A PACS watcher would care because the presentation gives investors exposure to the Company's leadership discussing its operations and growth strategy at a major industry conference.

PACS Expands Florida Footprint With 32-Facility Acquisition

Zacks Investment Research · 8 Sept 2026positive

PACS announced plans to acquire the operations of 32 skilled nursing facilities in Florida, adding 4,049 licensed beds. The acquisition is intended to establish a statewide network for the company in Florida.

Why it matters — The deal significantly expands PACS's presence in Florida, one of the state's largest skilled nursing markets, which could reshape its operational footprint and scale.

PACS Group: The Peer Check Stopped Me From Calling It Cheap

Seeking Alpha · 1 Sept 2026positive

A Seeking Alpha analyst rates PACS Group a Buy, valuing the shares at $49.58, about 17% above the August 31 closing price. Q2 revenue rose 9.1%, operating income grew 35.8%, same-store occupancy reached 90.6%, and the Eduro acquisition adds 3,633 beds.

Why it matters — PACS watchers would note the analyst's bullish valuation and strong quarterly operating metrics, including occupancy gains and the Eduro bed expansion, which inform forward growth expectations.

PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities

Business Wire · 1 Sept 2026positive

PACS Group announced that its subsidiaries have entered into definitive agreements to acquire the operations of 32 skilled nursing facilities in Florida, which will be leased from an existing REIT landlord, Omega Healthcare Investors. The facilities comprise a combined 4,049 licensed skilled nursing beds and are integrated into local healthcare networks.

Why it matters — This expansion adds a significant number of licensed beds in Florida, deepening PACS Group's operational footprint within local healthcare networks.

Zacks Industry Outlook CareDx, BrightSpring and PACS

Zacks Investment Research · 25 Aug 2026neutral

Zacks Investment Research published an Industry Outlook article highlighting CareDx, BrightSpring, and PACS Group, Inc. among noteworthy companies in the sector. No specific analysis or details beyond the companies being featured in the outlook were provided.

Why it matters — PACS watchers would care because the company received prominent coverage in a widely followed Zacks industry analysis, raising awareness among investors.

FAQ

Frequently asked questions about PACS stock

What is the PACS stock price forecast for 2026-2027?

The 6 Wall Street analysts covering PACS Group, Inc. have a median 12-month price target of $59, with estimates ranging from $57 to $62. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PACS stock a buy right now?

Of the 6 analysts covering PACS Group, Inc., 6 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks PACS Group, Inc. 93 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PACS?

As at 19 Sept 2026, PACS Group, Inc. ranks 93 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (97 of 100).

Will PACS stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts implies +40.1% from the last close, and Ticker Nerd's factor model ranks PACS Group, Inc. 93 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PACS stock forecast for 2030?

No analyst covering PACS Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PACS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $57 to $62 over the next 12 months.

How has PACS stock performed over the past year?

PACS Group, Inc. returned +251.0% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does PACS Group, Inc. do?

PACS Group, Inc. is a healthcare holding company focused on post-acute care services in the United States.

What is the latest news on PACS?

The most recent item we track (Business Wire, 14 Sept 2026): "PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026". PACS Group, Inc. announced that it will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026, in Nashville, TN. CEO and Chairman Jason Murray, CFO Carey Hendrickson, and COO Josh Jergensen will present on the Company's operations, growth strategy, and related information.

Company

About PACS Group, Inc.

PACS Group, Inc. is a healthcare holding company focused on post-acute care services in the United States. Through its subsidiaries, PACS Group operates skilled nursing facilities, assisted living communities, and independent living services, while also supporting care delivery with administrative, technology, training, and compliance functions. The company’s portfolio serves patients and residents who need rehabilitation, long-term support, or daily living assistance after hospital stays or as part of ongoing senior care. PACS Group also participates in the acquisition, ownership, and leasing of health care-related properties, giving it a role in both care operations and facility infrastructure. Based in Salt Lake City, Utah, PACS Group is positioned as a national platform in the post-acute and senior living markets.

CEO Mr. Jason Murray · 47,455 employees · United States · https://pacs.com